A Laboratory Course in BIOMATERIALS

A Laboratory Course in Biomaterials

Volumn , Issue , 2009, Pages 1-213

  Xian, Wujing ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85145618371     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b15832     Document Type: Book

References (56)

1. Cumming, G., F. Fidler, and D.L. Vaux, Error bars in experimental biology. J. Cell. Biol., 177, 7–11, 2007
2. Abazinge, M., T. Jackson, Q. Yang, and G. Owusu-Ababio, Comparison of in vitro and in vivo release characteristics of sustained release ofloxacin microspheres, Drug Deliv., 7, 77–81, 2000.
3. Freiberg, S., and X.X. Zhu, Polymer microspheres for controlled drug release, Int. J. Pharm., 282, 1–18, 2004.
4. Fu, K., D.W. Pack, A.M. Klibanov, and R. Langer, Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres, Pharm. Res., 17, 100–106, 2000.
5. Huang, X., and C.S. Brazel, On the importance and mechanisms of burst release in matrix-controlled drug delivery systems, J. Control Release 73, 121–136, 2001.
6. Kang, F., and J. Singh, Preparation, in vitro release, in vivo absorption and biocompatibility studies of insulin-loaded microspheres in rabbits, AAPS PharmSciTech., 6, E487–E494, 2005.
7. Katz, D.E., A.J. DeLorimier, M.K. Wolf, E.R. Hall, F.J. Cassels, J.E. van Hamont, R.L. Newcomer, M.A. Davachi, D.N. Taylor, and C.E. McQueen, Oral immunization of adult volunteers with microencapsulated enterotoxigenic escherichia coli (ETEC) cs6 antigen, Vaccine, 21, 341–346, 2003.
8. Putney, S.D., Encapsulation of proteins for improved delivery, Curr. Opin. Chem. Biol., 2, 548–552, 1998.
9. Ratner, B.D., A.S. Hoffman, F.J. Schoen, and J.E. Lemons, Biomaterials science: An introduction to materialsin medicine, 2nd ed., Elsevier Academic Press, Boston, 2004.
10. Shenderova, A., T.G. Burke, and S.P. Schwendeman, The acidic microclimate in poly(lactide-co-glycolide) microspheres stabilizes camptothecins, Pharm. Res., 16, 241–248, 1999.
11. Thomas, T.T., D.S. Kohane, A. Wang, and R. Langer, Microparticulate formulations for the controlled release of interleukin-2, J. Pharm. Sci., 93, 1100–1109, 2004.
12. Bella, J., M. Eaton, B. Brodsky, and H.M. Berman, Crystal and molecular structure of a collagen-like peptide at 1.9 Å resolution, Science, 266, 75–81, 1994.
13. Dutta, P.K., M.N.V. Ravikumar, and J. Dutta, Chitin and chitosan for versatile applications, J. Macromol. Sci. C-Pol. Rev., 42, 307–354, 2002.
14. Heino, J., The collagen family members as cell adhesion proteins, BioEssays, 29, 1001–1010, 2007.
15. Huc, A., and R. Gimeno. Process of Preparation of Collagen Containing in Major Proportion Insoluble Collagen and Collagen Having High Mechanical Resistance and Thermal Stability Obtained Thereby, Coletica, Lyons, France, U.S. Patent Office, Washington, D.C., 1994.
16. Lakes, R., Materials with structural hierarchy, Nature, 361, 511–515, 1993.
17. Lee, C.H., A. Singla, and Y. Lee, Biomedical applications of collagen, Int. J. Pharm., 221, 1–22, 2001.
18. Sun, Y.-L., Z.-P. Luo, A. Fertala, and K.-N. An, Direct quantification of the flexibility of type I collagen monomer, Biochem. Biophys. Res. Commun., 295, 382–86, 2002.
19. FDA, Use of international standard ISO-10993, Biological evaluation of medical devices, Part 1: Evaluation and testing, General Program Memorandum G95-1, GPO, Washington, D.C., 1995.
20. ISO, Biological evaluation of medical devices, Part 5: Tests for in vitro cytotoxicity, ISO 10993-5, 1999.
21. Kirkpatrick, C., F. Bittinger, M. Wagner, H. Köhler, T. van Kooten, C. Klein, and M. Otto, Current trends in biocompatibility testing, Proc. Inst. Mech. Eng. [H], 212, 75–84, 1998.
22. Mosmann, T., Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays, J. Immunol. Methods, 65, 55–63, 1983.
23. Williams, D.F., ed., Definitions in biomaterials. Proceedings of a Consensus Conference of the European Society for Biomaterials, Chester, England, 1986, Elsevier, Amsterdam, 1987.
24. ®) in difficult-to-heal venous leg ulcers, J. Wound Care, 11, 182–183, 2003.
25. Bouchie, A., Tissue engineering firms go under, Nat. Biotechnol., 20, 1178–1179, 2002.
26. Boyce, S., R. Kagan, D. Greenhalgh, P. Warner, K. Yakuboff, T. Palmieri, and G. Warden, Cultured skin substitutes reduce requirements for harvesting of skin autograft for closure of excised, full-thickness burns, J. Trauma., 60, 821–829, 2006.
27. Clark, R.A.F., K. Ghosh, and M.G. Tonnesen, Tissue engineering for cutaneous wounds, J. Invest. Dermatol., 127, 1018–1029, 2007.
28. Griffith, M., R. Osborne, R. Munger, X. Xiong, C.J. Doillon, N.L.C. Laycock, M. Hakim, Y. Song, and M.A. Watsky, Functional human corneal equivalents constructed from cell lines, Science, 286, 2169–2172, 1999.
29. Haddow, D., D. Steele, R. Short, R. Dawson, and S. Macneil, Plasma-polymerized surfaces for culture of human keratinocytes and transfer of cells to an in vitro wound-bed model, J. Biomed. Mater. Res. A, 64, 80–87, 2003.
30. Hermans, M.H., Clinical experience with glycerol-preserved donor skin treatment in partial thickness burns, Burns Incl. Therm. Inj., 15, 57–59, 1989.
31. Hu, J.C., and K.A. Athanasiou, A self-assembling process in articular cartilage tissue engineering, Tissue Eng., 12, 969–979, 2006.
32. Jarman-Smith, M., T. Bodamyali, C. Stevens, J. Howell, M. Horrocks, and J. Chaudhuri, Porcine collagen crosslinking, degradation and its capability for fibroblast adhesion and proliferation, J. Mater. Sci. Mater. Med., 15, 925–932, 2004.
33. Kumar, R.J., R.M. Kimble, R. Boots, and S.P. Pegg, Treatment of partial-thickness burns: A prospective randomized trial using TranscyteTM, ANZ J. Surg., 74, 622–626, 2004.
34. Limat, A., L.E. French, L. Blal, J.H. Saurat, T. Hunziker, and D. Salomon, Organotypic cultures of autologous hair follicle keratinocytes for the treatment of recurrent leg ulcers, J. Am. Acad. Dermatol., 48, 207–214, 2003.
35. Lipkin, S., E. Chaikof, Z. Isseroff, and P. Silverstein, Effectiveness of bilayered cellular matrix in healing of neuropathic diabetic foot ulcers: Results of a multicenter pilot trial, Wounds, 15, 230–236, 2003.
36. Maas-Szabowski, N., A. Stärker, and N.E. Fusenig, Epidermal tissue regeneration and stromal interaction in HaCaT cells is initiated by TGF-α, J. Cell. Sci., 116, 2937–2948, 2003.
37. MacNeil, S., Progress and opportunities for tissue-engineered skin, Nature, 445, 874–880, 2007.
38. Marston, W.A., J. Hanft, P. Norwood, and R. Pollak, The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: Results of a prospective randomized trial, Diabetes Care, 26, 1701–1705, 2003.
39. Navarro, F., M. Stoner, C. Park, J. Huertas, H. Lee, F. Wood, and D. Orgill, Sprayed keratinocyte suspensions accelerate epidermal coverage in a porcine microwound model, J. Burn Care Rehabil., 21, 513–518, 2000.
40. NIH (National Institutes of Health), PAR-06-504: Enabling technologies for tissue engineering and regenerative medicine, Department of Health and Human Services, Washington, DC, 2006.
41. O’Connor, N.E., J.B. Mulliken, S. Banks-Schlegel, O. Kehinde, and H. Green, Grafting of burns with cultured epithelium prepared from autologous epidermal cells, Lancet, 1(8211), 75–78, 1981.
42. Pastore, S., F. Mascia, V. Mariani, and G. Girolomoni, The epidermal growth factor receptor system in skin repair and inflammation, J. Invest. Dermatol., 128, 1365–1374, 2007.
43. Roos, E., C. O’Reilly, R. Chevere, and L.M. Wilkins, U.S. patent no. 6,730,510 B2: Culture dish and bioreactor system, Organogenesis, Inc., Canton, MA, 2004.
44. Russell, S.B., J.D. Russell, and K.M. Trupin, Collagen synthesis in human fibroblasts: Effects of ascorbic acid and regulation by hydrocortisone, J. Cell. Physio., 109, 121–131, 1981.
45. Shen, G., H.C. Tsung, C.F. Wu, X.Y. Liu, X.Y. Wang, W. Liu, L. Cui, and Y.L. Cao, Tissue engineering of blood vessels with endothelial cells differentiated from mouse embryonic stem cells, Cell Res., 13, 335–341, 2003.
46. Stark, H.-J., A. Szabowski, N.E. Fusenig, and N. Maas-Szabowski, Organotypic cocultures as skin equivalents: A complex and sophisticated in vitro system, Biol. Proced. Online, 6, 55–60, 2004.
47. Stern, R., M. McPherson, and M.T. Longaker, Histologic study of artificial skin used in the treatment of full thickness thermal injury, J. Burn Care Rehabil., 11, 7–13, 1990.
48. Tausche, A., M. Skaria, L. Böhlen, K. Liebold, J. Hafner, H. Friedlein, M. Meurer, R. Goedkoop, U. Wollina, D. Salomon, and T. Hunziker, An autologous epidermal equivalent tissue-engineeredfrom follicular outer root sheath keratincoytes is as effective as split-thickness skin autograft in recalcitrant vascular leg ulcers, Wound Repair Regen., 11, 248–252, 2003.
49. Wainwright, D., M. Madden, A. Luterman, J. Hunt, W. Monafo, D. Heimbach, R. Kagan, K. Sittig, A. Dimick, and D. Herndon, Clinical evaluation of an acellular allograft dermal matrix in full- thickness burns, J. Burn Care Rehabil., 17, 124–136, 1996.
50. Wright, K., K. Nadire, P. Busto, R. Tubo, J. McPherson, and B. Wentworth, Alternative delivery of keratinocytes using a polyurethane membrane and the implications for its use in the treatment of full-thickness burn injury, Burns, 24, 7–17, 1998.
51. de Leeuw, N., Local ordering of hydroxy groups in hydroxyapatite, Chem. Commun., 1646–1647, 2001.
52. Farley, J., J. Wergedal, and D. Baylink, Fluoride directly stimulates proliferation and alkaline phosphatase activity of bone-forming cells, Science, 222, 330–332, 1983.
53. Hammond, C., The basics of crystallography and diffraction, 2nd ed., Oxford University Press, 2001.
54. Liu, C., Y. Huang, W. Shen, and J. Cui, Kinetics of hydroxyapatite precipitation at pH 10 to 11, Biomaterials 22, 301–306, 2001.
55. Santos, M.H., M. de Oliveira, L.P. de Freitas Souza, H.S. Mansur, and W.L. Vasconcelos, Synthesis control and characterization of hydroxyapatite prepared by wet precipitation process, Mat. Res., 7, 625–630, 2004.
56. Vallet-Regí, M., Ceramics for medical applications, J. Chem. Soc., Dalton Trans., 97–108, 2001.